CGBIO Hosts Large-Scale LUMFIX and NOVOSIS Workshop in Indonesia… Establishing a Self-Sustaining Medical Education Ecosystem

• DATE 2024-09-30
• VIEWSViews : 712 views

Innosys Brings Innovative Spine Treatment Device, L’DISQ, to Indonesia to Improve Lives

• DATE 2024-09-10
• VIEWSViews : 1,189 views

CGBIO Bone Substitute ‘NOVOSIS’ Expands Indications through Reverse Innovation in Indonesia

• DATE 2024-08-08
• VIEWSViews : 1,481 views

CGBIO Drives Market Penetration in Latin America with Differentiated Technology… Showcases Diverse Medical Devices at FIME

• DATE 2024-07-12
• VIEWSViews : 745 views

CGBIO’s Biliary Stent ‘ARISTENT’ Receives PMDA Approval in Japan… “Accelerating Global Expansion Starting with Japanese Market”

• DATE 2024-07-04
• VIEWSViews : 1,302 views

CGBIO Shares Clinical Utility of ‘Regenerative Medicine Solutions’ at World Foot and Ankle Congress

• DATE 2024-07-04
• VIEWSViews : 761 views

CGBIO Unveils Latest Spinal Fusion Techniques at Global Spine Congress ‘GSC 2024’

• DATE 2024-06-24
• VIEWSViews : 1,080 views

Innosys Receives US FDA Approval for ‘UniSpace,’ a Cervical Cage Incorporating 3D Printing Technology

• DATE 2024-06-18
• VIEWSViews : 1,521 views

CGBIO’s ‘EasyDew MD Regen Cream’ Rapidly Restores Skin Barrier after Laser Treatment

• DATE 2024-06-11
• VIEWSViews : 1,756 views

CGBIO Achieves Record Sales of 156.7 Billion Won, Operating Profit of 20.4 Billion Won in 2023… “Capturing Both External and Internal Growth, Delivering All-Time High Performance”

• DATE 2024-05-24
• VIEWSViews : 1,444 views